Literature DB >> 3522508

Effects of piracetam on developmental dyslexia.

C R Wilsher.   

Abstract

A new class of drugs (nootropics) are viewed from the perspective of their neuropsychological effect upon developmental dyslexia. Evidence from both the preclinical and clinical work conducted on Piracetam is briefly reviewed. The latest research on the effects of Piracetam in dyslexia shows a convergence of results. Attempts to replicate these results with dyslexia have only met with success in the areas of reading rate. In an attempt to find an independent replication of the Chase et al. (1984) finding, the author provides additional evidence on the effects of Piracetam on reading Rate X Accuracy in dyslexics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3522508     DOI: 10.1016/0167-8760(86)90048-6

Source DB:  PubMed          Journal:  Int J Psychophysiol        ISSN: 0167-8760            Impact factor:   2.997


  3 in total

1.  The nootropic concept and dyslexia.

Authors:  C R Wilsher
Journal:  Ann Dyslexia       Date:  1986-01

Review 2.  Piracetam in developmental reading disorders: A review.

Authors:  Colin R Wilsher; Eric A Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  1994-04       Impact factor: 4.785

3.  Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.

Authors:  Kristina Leuner; Christopher Kurz; Giorgio Guidetti; Jean-Marc Orgogozo; Walter E Müller
Journal:  Front Neurosci       Date:  2010-09-07       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.